Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefani Spranger

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|September 18, 2015
A new paradigm for tumor immune escape: β-catenin-driven immune exclusionStefani Spranger, Thomas F Gajewski
Oncoimmunology|May 4, 2016
Tumor-intrinsic oncogene pathways mediating immune avoidanceStefani Spranger, Thomas F Gajewski
Nature Immunology|February 19, 2020
CD36 - the Achilles' heel of T<sub>reg</sub> cellsBrendan L Horton, Stefani Spranger
Emerging Topics in Life Sciences|February 2, 2021
The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutionsBrendan L Horton, Stefani Spranger
Science Immunology|January 17, 2025
Architects of immunity: How dendritic cells shape CD8<sup>+</sup> T cell fate in cancerVidit Bhandarkar, Teresa Dinter, Stefani Spranger
Journal for Immunotherapy of Cancer|October 6, 2020
Impact of anatomic site on antigen-presenting cells in cancerMaria Zagorulya, Ellen Duong, Stefani Spranger
Journal for Immunotherapy of Cancer|July 11, 2018
A team effort: natural killer cells on the first leg of the tumor immunity relay raceTimothy B Fessenden, Ellen Duong, Stefani Spranger
Nature|May 14, 2015
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunityStefani Spranger, Riyue Bao, Thomas F Gajewski
Cell Research|April 27, 2016
MYC - a thorn in the side of cancer immunityStefani Spranger, Thomas F Gajewski, Justin Kline
Journal of Translational Medicine|February 28, 2012
NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivoStefani Spranger, Bernhard Frankenberger, Dolores J Schendel
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|September 18, 2015
A new paradigm for tumor immune escape: β-catenin-driven immune exclusionStefani Spranger, Thomas F Gajewski
Oncoimmunology|May 4, 2016
Tumor-intrinsic oncogene pathways mediating immune avoidanceStefani Spranger, Thomas F Gajewski
Nature Immunology|February 19, 2020
CD36 - the Achilles' heel of T<sub>reg</sub> cellsBrendan L Horton, Stefani Spranger
Emerging Topics in Life Sciences|February 2, 2021
The non-T-cell-inflamed tumor microenvironment: contributing factors and therapeutic solutionsBrendan L Horton, Stefani Spranger
Science Immunology|January 17, 2025
Architects of immunity: How dendritic cells shape CD8<sup>+</sup> T cell fate in cancerVidit Bhandarkar, Teresa Dinter, Stefani Spranger
Journal for Immunotherapy of Cancer|October 6, 2020
Impact of anatomic site on antigen-presenting cells in cancerMaria Zagorulya, Ellen Duong, Stefani Spranger
Journal for Immunotherapy of Cancer|July 11, 2018
A team effort: natural killer cells on the first leg of the tumor immunity relay raceTimothy B Fessenden, Ellen Duong, Stefani Spranger
Nature|May 14, 2015
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunityStefani Spranger, Riyue Bao, Thomas F Gajewski
Cell Research|April 27, 2016
MYC - a thorn in the side of cancer immunityStefani Spranger, Thomas F Gajewski, Justin Kline
Journal of Translational Medicine|February 28, 2012
NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivoStefani Spranger, Bernhard Frankenberger, Dolores J Schendel
Pageof 9